학술논문
Interim analysis (n=200) of ELEANOR: a multi-national, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib in the clinical routine
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
22965262